Cytek Biosciences, Inc. (CTKB) reported revenue at $57.5 million

Cytek Biosciences, Inc. (NASDAQ: CTKB) reported revenue for the quarter came in at $57.5 million versus the consensus estimate of $61.49 million.

For earnings history and earnings-related data on Cytek Biosciences, Inc. (CTKB) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• China retail sales growth slows to 0.6% in July, Macquarie comments
• NAHB housing market index rises to 35 in August from 34